Ruminant Biotech, a New Zealand-based tech business looking to reduce methane emissions from pasture-based livestock, has raised around $9.5m in a Series A fundraising.
The Rmb2.5bn 2.0% notes are the German carmaker’s third onshore Renminbi bond issuance. The company told FA that the move is part of its funding diversification efforts.
The HKMA and CMU OmniClear are leading Hong Kong’s ambitions to internationalise the use of Chinese bonds in global trading. The development of the innovative infrastructure represents a breakthrough for Rmb repos, clearing, settlement and custody.
The $400m deal will see global PE firm acquire up to 54% of equity from CVC, and up to a total 77% stake of the Indian cancer care specialist; KKR made several significant investments into Indian healthcare firms last year, as regional PE deals bounceback.